ImageneBio, Inc.
IMA
$5.52
-$0.04-0.63%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 0.00 | 800.00K | 800.00K | 4.30M | 4.30M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.00 | 800.00K | 800.00K | 4.30M | 4.30M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 0.00 | 800.00K | 800.00K | 4.30M | 4.30M |
| SG&A Expenses | 24.09M | 20.73M | 17.88M | 8.49M | 8.70M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 54.54M | 49.25M | 46.89M | 25.83M | 24.86M |
| Operating Income | -54.54M | -48.45M | -46.09M | -21.53M | -20.56M |
| Income Before Tax | -50.23M | -45.70M | -43.31M | -21.64M | -20.32M |
| Income Tax Expenses | -340.00K | -350.00K | -61.00K | 13.00K | 13.00K |
| Earnings from Continuing Operations | -49.89 | -45.35 | -43.25 | -21.66 | -20.33 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -49.89M | -45.35M | -43.25M | -21.66M | -20.33M |
| EBIT | -54.54M | -48.45M | -46.09M | -21.53M | -20.56M |
| EBITDA | -54.04M | -48.05M | -46.07M | -21.44M | -20.02M |
| EPS Basic | -11.46 | -14.31 | -13.71 | -11.49 | -3.97 |
| Normalized Basic EPS | -5.74 | -6.73 | -6.33 | -4.94 | -1.59 |
| EPS Diluted | -11.46 | -14.31 | -13.71 | -11.49 | -3.97 |
| Normalized Diluted EPS | -5.74 | -6.73 | -6.33 | -4.94 | -1.59 |
| Average Basic Shares Outstanding | 34.99M | 26.18M | 477.10M | 465.92M | 464.51M |
| Average Diluted Shares Outstanding | 34.99M | 26.18M | 477.10M | 787.39M | 1.11B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |